Evidence of Clonal Hematopoiesis and Risk of Heart Failure
Title
Evidence of Clonal Hematopoiesis and Risk of Heart Failure
Creator
Peter Bazeley; Rommel Morales; W. H. Wilson Tang
Publisher
Current Heart Failure Reports
Date
2020
Description
Purpose of Review
Clonal hematopoiesis of indeterminate potential (CHIP) is characterized by persistent clonal expansion of adult hematopoietic stem cells, which has been increasingly found to be associated with cardiovascular disease and adverse outcomes in heart failure. Here we outline emerging studies on the prevalence of CHIP, and its association with cardiovascular and heart disease.
Recent Findings
Previous genomic studies have found CHIP mutations to be associated with increased risks of arterial disease, stroke, and mortality. Murine studies exploring TET2, DNMT3A, and JAK2 mutations have shown changes in cellularity that decrease cardiac function after insult, as well as increase inflammasome activation.
Summary
Mutations in driver genes are associated with worse clinical outcomes in heart failure patients, as a potential result of the proinflammatory selection in clonal hematopoiesis. Advances in the field have yielded therapeutic targets tested in recent clinical studies and may provide a valuable diagnostic of risk in heart failure.
Clonal hematopoiesis of indeterminate potential (CHIP) is characterized by persistent clonal expansion of adult hematopoietic stem cells, which has been increasingly found to be associated with cardiovascular disease and adverse outcomes in heart failure. Here we outline emerging studies on the prevalence of CHIP, and its association with cardiovascular and heart disease.
Recent Findings
Previous genomic studies have found CHIP mutations to be associated with increased risks of arterial disease, stroke, and mortality. Murine studies exploring TET2, DNMT3A, and JAK2 mutations have shown changes in cellularity that decrease cardiac function after insult, as well as increase inflammasome activation.
Summary
Mutations in driver genes are associated with worse clinical outcomes in heart failure patients, as a potential result of the proinflammatory selection in clonal hematopoiesis. Advances in the field have yielded therapeutic targets tested in recent clinical studies and may provide a valuable diagnostic of risk in heart failure.
Subject
CHIP; Clonal hematopoiesis; Heart failure; Ten-eleven translocation-2; Janus kinase 2; Inflammasome
Identifier
Rights
Article information provided for research and reference use only. All rights are retained by the journal listed under publisher and/or the creator(s).
Format
journalArticle
URL Address
Search for Full-text
Users with a NEOMED Library login can search for full-text journal articles at the following url: https://libraryguides.neomed.edu/home
NEOMED College
NEOMED College of Medicine
NEOMED Department
NEOMED Student Publications
Citation
Peter Bazeley; Rommel Morales; W. H. Wilson Tang, “Evidence of Clonal Hematopoiesis and Risk of Heart Failure,” NEOMED Bibliography Database, accessed April 19, 2024, https://neomed.omeka.net/items/show/11170.